Source Fact: Financial Supervisory Service DART / 2024-05-17
Disclosure Type: Additional Listing (Exercise of Stock Options)
💡 3-Second Summary
Alteogen will issue and list 136,700 additional common shares on May 22 following the exercise of employee stock options, with exercise prices ranging from a minimum of KRW 8,889 to a maximum of KRW 72,875 per share.
📊 1. [Summary of Core Disclosure Content and Major Figures]
- Company Name: Alteogen Co., Ltd. (Ticker: 196170)
- Type and Number of Additional Shares: 136,700 Common Shares
- Par Value per Share: KRW 500
- Reason for Additional Listing: Exercise of stock options (Exercise Date: May 03, 2024)
- Detailed Issuance Breakdown:
- 95th Round: 16,000 shares (Exercise Price: KRW 8,889)
- 96th Round: 20,100 shares (Exercise Price: KRW 10,000)
- 97th Round: 60,000 shares (Exercise Price: KRW 8,917)
- 98th Round: 22,400 shares (Exercise Price: KRW 21,111)
- 99th Round: 8,600 shares (Exercise Price: KRW 23,833)
- 100th Round: 9,600 shares (Exercise Price: KRW 72,875)
- Total Outstanding Shares Post-Listing: 53,148,528 Common Shares
- Listing Date: May 22, 2024
- Dividend Base Date: January 01, 2024
📈 2. [Expert View: What This Disclosure Means for Investors]
This filing announces an increase in capital stock resulting from the conversion of employee stock options into tradable equity. This action functions as a quantitative supply event and does not modify the structural business fundamental, such as revenue lines or biological pipeline progressions, and should be evaluated primarily as a short-term liquidity and supply event.
The potential risk factors that market participants should monitor involve share dilution and subsequent overhang pressures. The incoming 136,700 shares account for a limited portion (approximately 0.26%) of the expanded outstanding shares (53,148,528 shares). However, because the preset exercise prices for the majority of the rounds (KRW 8,889 to KRW 23,833) reside significantly below the prevailing market price at the disclosure timeline, option holders face compelling incentives to execute immediate profit-taking sales. Consequently, a practical approach requires investors to treat the listing date (May 22) and its immediate aftermath as a window of potential short-term market volatility.
📝 Editor’s Comment (by K-STOCK Editor)
A batch of stock options held by Alteogen’s internal staff has officially been converted into shares, hitting the market on May 22. While the headline total of over 130,000 shares translates to just 0.26% of total outstanding shares, the core factor to emphasize is the deep discount on the exercise prices. With entry points for most tranches fixed around KRW 10,000, these shares hold substantial unrealized gains relative to current trading values. This valuation gap sets up a high probability for immediate post-listing liquidation from the holders. Investors would be wise to tone down any short-term optimism and carefully map volume changes around the listing frame.
📢 Disclaimer and Source Information
Source: This content has been structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.
Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.
🔥 Bulls vs Bears, drop your analysis in the comments!
